|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Money market investments | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Trading securities, at fair value, with amortized cost of $163 (December 31, 2025 - $163) | ||||||||||||||||||||
| Investment securities available-for-sale, at fair value, with amortized cost of $2,566,254 (December 31, 2025 - $2,529,325); no allowance for credit losses | ||||||||||||||||||||
| Investment securities held-to-maturity, at amortized cost, with fair value of $197,670 (December 31, 2025 - $225,065); no allowance for credit losses | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Loans: | ||||||||||||||||||||
| Loans held-for-sale, at lower of cost or fair value | ||||||||||||||||||||
| Loans held-for-investment, net of allowance for credit losses of $191,829 (December 31, 2025 - $202,341) | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Other assets: | ||||||||||||||||||||
| Foreclosed real estate | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Customers’ liability on acceptances | ||||||||||||||||||||
| Servicing assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Demand deposits | ||||||||||||||||||||
| Savings accounts | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings: | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Advances from the FHLB | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Total borrowings | ||||||||||||||||||||
| Other liabilities: | ||||||||||||||||||||
| Acceptances executed and outstanding | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $1 par value; 100,000,000 shares authorized; 59,885,234 shares issued: 42,004,638 shares outstanding (December 31, 2025 - 59,885,234 shares issued; 43,257,167 shares outstanding) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Legal surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost, 17,880,596 shares (December 31, 2025 - 16,628,067 shares) | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax of $27,029 (December 31, 2025 - $1,537) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...